USPTO serial 79421240
FILIGRAPH
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- Mar 17, 2026
- Examiner
- ELTON, DAVID JONATHAN
- Law office
- FILE REPOSITORY (FRANCONIA)
What this means
Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.
Need help with FILIGRAPH?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
David Youngjoon Jung
David Youngjoon Jung KAIROS Law Firm, PLLC2001 L Street N.W. Suite 500Washington, DC 20036United StatesGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 005 | Injectable dermal fillers; pre-filled syringes for medical purposes filled with saline for rehydrating the skin; pre-filled syringes for medical purposes filled with pharmaceuticals for dissolving skin wrinkles; pre-filled syringes for medical purposes filled with pharmaceuticals for rehydrating the skin; pre-filled syringes for medical purposes filled with hyaluronic acid for pharmaceutical purposes; pre-filled syringes for medical purposes filled with hyaluronic acid preparations for facial and body skin tightening and smoothing; pre-filled syringes for medical purposes filled with botulinum toxin for the treatment of wrinkles; pre-filled syringes for medical purposes filled with botulinum toxin for medical use for use in the treatment of excessive sweating, excessive eye blinking, neuropathy pain, facial wrinkles, headache, pain, spasm, dystonia, urogenital system diseases and conditions, skin disorders; pre-filled syringes for medical purposes filled with pain relief medication; pre-filled syringes for medical purposes filled with hyaluronic acid for dissolving skin wrinkles; filled syringes for medical purposes filled with pharmaceuticals for rehydrating the skin, dissolving skin wrinkles; filled syringes for medical purposes filled with hyaluronic acid for dissolving skin wrinkles; drugs for medical purposes, namely, pain relief medications; drugs for medical purposes, namely, pharmaceutical preparations for the treatment of neurological disorders, muscle dystonias, smooth muscle disorders, autonomic nerve disorders, headaches, wrinkles, hyperhidrosis and cerebral palsy; drugs for medical purposes for the treatment of sports related injuries, namely, injured or torn skin, muscle, ligaments or bone; drugs for medical purposes, namely, pharmaceutical preparations for treating and preventing tendon and muscle injuries and disorders, sports related injuries, and for knee cartilage regeneration; drugs for medical purposes for the treatment of tremors, namely, spasmodic smooth, striated or cardiac muscles; drugs for medical purposes for the treatment of pain, namely, smooth muscle pain, striated muscle pain, cardiac muscle pain, neuropathic pain, inflammatory pain, visceral pain, chronic pain, acute pain, traumatic injury pain, referred pain, growing pain, hunger pain, intractable pain, labor pain, organic pain, phantom limb pain, postprandial pain, psychogenic pain, back pain, post-stroke pain, cancer pain, nociceptive pain, headache pain, prostatic pain, and bladder pain; drugs for medical purposes, namely, therapeutic drugs and agents for use in the treatment of excessive sweating, excessive eye blinking, neuropathy pain, facial wrinkles, headache, pain, spasm, dystonia, urogenital system diseases and conditions, skin disorders; pharmacological preparations for skin care; tissue-regenerative pharmaceutical preparations; pharmaceutical preparations for use in dermatology; skin care preparations for medical purposes; tissues impregnated with pharmaceutical lotions for sunburn, skin conditions, treating eczema; medicated ointments for treating dermatological conditions; ointments for pharmaceutical purposes, namely, medicated ointments for treating dermatological conditions; antibiotic ointments for pharmaceutical purposes; anti-itch ointments for pharmaceutical purposes; medicated lotions and creams for the body, skin, face, and hands; medicated skin lotions; medicated lotions for treating dermatological conditions; medicated lotions for skin, hair, sunburn, face, body and hands; medicated pharmaceutical skin lotions; medicines for humans for treating dermatological conditions; medicines for humans, namely, medicines for skin care; medicines for humans, namely, antiallergic medicines; medicines for human purposes being antivirals; medicines for human purposes, namely, medicinal preparations for the mouth to be applied in the form of drops, capsules, tablets and compressed tablets; medicines for human purposes for the treatment of cardiovascular and cerebrovascular diseases; implants comprising living tissue; skin grafts; hyaluronic acid mixed with its derivatives and other polysaccharides, including or not including lidocaine, in ampoule form for medical purposes; hyaluronic acid preparations for medical purposes; hyaluronic acid-based preparations for pharmaceutical purposes; syringes sold filled with hyaluronic acid pharmaceutical preparations for medical purposes; pharmaceutical preparations for the treatment of wrinkles; pharmacological preparations for cosmetic treatment, namely, medicated cosmetics; pharmacological preparations for cosmetic treatment, namely, pharmaceutical preparations for treating skin disorders; pharmacological preparations for cosmetic treatment, namely, pharmaceutical preparations mainly based on hyaluronic acid for treatments, namely, injectable for intradermal and subcutaneous application for facial and body skin tightening and smoothing; modified hyaluronic acid preparations for medical purposes; medical topical gels for activation of skin tissues; filler for urological purposes being injectable dermal fillers; self-injection syringes for medical purposes for injection of prefilled hyaluronic acid; pharmacological preparations for cosmetic surgery, namely, anesthetics for surgery, medicated ointment for treating dermatological conditions; filler for plastic surgery being injectable dermal fillers; biological biomaterials for tissue restoration for medical purposes; filler for dermatology being injectable dermal fillers. | ACTIVE | — |
| 010 | Medical apparatus for injecting fillers; bone void fillers comprised of artificial materials; injection device for pharmaceuticals; syringes for medical purposes; disposable hypodermic syringes for medical use; hypodermic syringes for use in administering injection substances; syringes for injections; medical apparatus and instruments for the treatment of skin; medical apparatus and instruments for plastic surgery; artificial implants for skin regeneration; artificial biomaterials for dermatology in the nature of artificial biomaterials for augmentation of tissue for dermatological purposes; medical skin enhancement apparatus using lasers; medical esthetic machine for skin massage; medical apparatus for skin wrinkle removal; medical instruments, namely, surgical thread; medical instruments, namely, laser instruments for medical use; medical instruments, namely, orthopedic apparatus and instruments; medical instruments, namely, biosensors for detecting infectious diseases; medical apparatus and instruments, namely, surgical apparatus and instruments; medical bone prostheses; medical prostheses for breast, hand, shoulder, hip; medical joint prostheses; medical apparatus, namely, lasers for the cosmetic treatment of the face and skin; medical apparatus, namely, infusion and injection devices for administering drugs; medical apparatus, namely, electronic light therapy apparatus for the skin; filler injectors for medical purposes; medical apparatus and instruments for urological purposes; medical apparatus for introducing pharmaceutical preparations into the human body; artificial implants for medical, surgical, urological, dermatological and plastic surgery; electric injection apparatus for medical purposes; dermic implants including visco-supplementation substances for medical use, intended for wrinkle filling or volume increasing, namely, artificial skin for surgical use; medical apparatus and instruments for dermatological use; syringes for injection of medical substances for the skin used for injection of a hyaluronic acid gel in a pre-filled syringe for reducing wrinkles, filling scars and contouring the lips and face. | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Sep 24, 2026 | OPNX | NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB | — |
| Sep 17, 2026 | FINO | FINAL DECISION TRANSACTION PROCESSED BY IB | — |
| Sep 9, 2026 | OPNS | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB | — |
| Sep 9, 2026 | OPNR | NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB | — |
| Aug 27, 2026 | FICS | FINAL DISPOSITION NOTICE SENT TO IB | — |
| Aug 27, 2026 | FIMP | FINAL DISPOSITION PROCESSED | — |
| Jun 17, 2026 | FICR | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB | — |
| Mar 26, 2026 | TCCA | TEAS CHANGE OF CORRESPONDENCE RECEIVED | — |
| Mar 26, 2026 | ECDR | TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS | — |
| Mar 26, 2026 | ARAA | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Mar 26, 2026 | REAP | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | — |
| Mar 17, 2026 | NRCC | NOTICE OF REGISTRATION CONFIRMATION EMAILED | — |
| Mar 17, 2026 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Jan 27, 2026 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Jan 27, 2026 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Jan 21, 2026 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Dec 31, 2025 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Dec 21, 2025 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Dec 20, 2025 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Dec 20, 2025 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Aug 23, 2025 | RFNT | REFUSAL PROCESSED BY IB | — |
| Aug 6, 2025 | RFCS | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | — |
| Aug 6, 2025 | RFRR | REFUSAL PROCESSED BY MPU | — |
| Jun 18, 2025 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| Jun 17, 2025 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jun 9, 2025 | DOCK | ASSIGNED TO EXAMINER | — |
| Apr 11, 2025 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Apr 11, 2025 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Apr 10, 2025 | REPR | SN ASSIGNED FOR SECT 66A APPL FROM IB | — |